CD4 and adult T-cell leukemia/lymphoma: To understand the mechanisms governing the role of IRF4 in the pathogenesis of ATLL and to discover potential biomarkers for ATLL therapy, we sought to identify downstream targets of IRF4 signaling in CD4 + T-cells in vivo.